Global Neurodiagnostics Market

Global Neurodiagnostics Market Size, Share, Growth Analysis, By Condition(Neuro Degenerative Diseases, Epilepsy), By End User(Hospitals & Surgery Centers, Diagnostic Laboratories & Imaging Centers) - Industry Forecast 2024-2031

Report ID: SQMIG35D2139 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 67 | Figures: 75

Global Neurodiagnostics Market News

  • In April 2022, Siemens Healthineers, headquartered in Germany, introduced the MAGNETOM Free.Max, the world's first 80 centimeter bore magnetic resonance imaging (MRI) system. This innovation aims to enhance patient comfort and accommodate individuals with claustrophobia or larger body types, while maintaining high-quality neuroimaging capabilities.
  • In February 2022, Medtronic, a leading medical technology company based in Ireland, announced the launch of its Percept PC deep brain stimulation (DBS) system with BrainSense technology in the United States. The system enables personalized, adaptive DBS therapy for patients with Parkinson's disease, essential tremor, and dystonia, providing real-time data and insights to optimize treatment outcomes.
  • In November 2021, Philips Healthcare, headquartered in the Netherlands, introduced the Philips Zenition 70 mobile C-arm imaging platform. This system integrates 3D imaging, real-time image guidance, and advanced visualization capabilities, providing neurosurgeons with enhanced intraoperative imaging and navigation for complex neurosurgical procedures.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Neurodiagnostics Market size was valued at USD 7.45 billion in 2022 and is poised to grow from USD 7.97 billion in 2023 to USD 13.70 billion by 2031, growing at a CAGR of 7% during the forecast period (2024-2031).

The global neurodiagnostics market features a competitive landscape with several key players vying for market share and striving for innovation in the field of neurological diagnostics. These companies focus on developing advanced neurodiagnostic devices, expanding their product portfolios, and strengthening their distribution networks to gain a competitive edge. The competitive landscape is characterized by a mix of established multinational corporations and emerging players specializing in neurodiagnostics. Collaborations, partnerships, and mergers and acquisitions are common strategies adopted by companies in the neurodiagnostics market. These collaborations enable knowledge sharing, technology transfer, and market expansion. Moreover, partnerships with academic institutions, research centers, and healthcare providers facilitate clinical trials, data collection, and validation of neurodiagnostic devices. 'Siemens Healthineers (Germany)', 'GE Healthcare (US)', 'Philips Healthcare (Netherlands)', 'Medtronic (Ireland)', 'Hitachi Medical Corporation (Japan)', 'Natus Medical Incorporated (US)', 'Abbott Laboratories (US)', 'Koninklijke Philips N.V. (Netherlands)', 'Thermo Fisher Scientific Inc. (US)', 'Elekta AB (Sweden)', 'Brainlab AG (Germany)', 'Masimo Corporation (US)', 'Cadwell Industries Inc. (US)', 'Advanced Brain Monitoring, Inc. (US)', 'Compumedics Limited (Australia)', 'Neurosoft Ltd. (Russia)', 'Magstim (UK)', 'NeuroWave Systems Inc. (US)', 'BrainScope Company Inc. (US)', 'Blackrock Microsystems LLC (US)'

The rising prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and epilepsy, is a major driver for the neurodiagnostics market. As the global population ages and lifestyles change, the burden of neurological disorders is increasing. This drives the demand for neurodiagnostic procedures to accurately diagnose and monitor these conditions.

Integration of Data Analytics and Cloud Computing: The integration of data analytics and cloud computing in neurodiagnostics is gaining traction. The ability to store and analyze large volumes of patient data in the cloud enables efficient data management, remote collaborations, and the development of predictive models for better diagnosis and treatment planning. This trend promotes data-driven decision-making and personalized patient care in neurodiagnostics.

North America emerges as the dominating region in the global neurodiagnostics market. The region's dominance can be attributed to several factors, including advanced healthcare infrastructure, robust research and development activities, and high healthcare expenditure. North America is home to numerous prominent neurodiagnostic device manufacturers, research institutes, and academic centers specializing in neurological disorders. Moreover, the region experiences a high prevalence of neurological conditions, driving the demand for neurodiagnostic procedures. The presence of well-established healthcare systems, reimbursement frameworks, and skilled healthcare professionals further contribute to the dominance of North America in the neurodiagnostics market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Global Neurodiagnostics Market

Report ID: UCMIG35D2245 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Cell & Gene Therapy Bioanalytical Testing Services Market
Buy Now GET FREE SAMPLE
Global Neurodiagnostics Market

Report ID: SQMIG35D2134 | Region: Global | Published Date: April, 2024 | Pages: 157 | Tables: 61 | Figures: 75

Global Cochlear Implant Market
Buy Now GET FREE SAMPLE
Global Neurodiagnostics Market

Report ID: UCMIG35D2177 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Podiatry Services Market
Buy Now GET FREE SAMPLE
Global Neurodiagnostics Market

Report ID: UCMIG35D2067 | Region: Global | Published Date: April, 2024 | Pages: 165 | Tables: Figures:

Hemodialysis and Peritoneal Dialysis Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Neurodiagnostics Market

Product ID: SQMIG35D2139

$5,300
BUY NOW GET FREE SAMPLE